Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011 (2011), Article ID 745340, 9 pages
http://dx.doi.org/10.1155/2011/745340
Research Article

Novel Biphasic Role of LipoxinA4 on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts

1Department of Anaesthesia, Second Affiliated Hospital of WenZhou Medical College, Zhejiang 325003, China
2Department of Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, Hubei Province 430030, China
3Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK
4Academic Department of Critical Care, Resuscitation, Anaesthesia, and Pain, Heart of England NHS Foundation Trust, Birmingham B9 5SS, UK

Received 15 February 2011; Accepted 3 May 2011

Academic Editor: Donna-Marie McCafferty

Copyright © 2011 Shengxing Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kirpalani and J. Gauldie, “Differentiation and effector function of pulmonary fibroblasts,” in Asthma and Rhinitis, W. W. Busse and S. T. Holgate, Eds., pp. 539–553, Blackwell Scientific, Boston, Mass, USA, 1995. View at Google Scholar
  2. C. D. Buckley, D. Pilling, J. M. Lord, A. N. Akbar, D. Scheel-Toellner, and M. Salmon, “Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation,” Trends in Immunology, vol. 22, no. 4, pp. 199–204, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Smith, T. J. Smith, T. M. Blieden, and R. P. Phipps, “Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation,” The American Journal of Pathology, vol. 151, no. 2, pp. 317–322, 1997. View at Google Scholar · View at Scopus
  4. A. Zdařilová, A. R. Svobodová, K. Chytilová, V. Šimánek, and J. Ulrichová, “Polyphenolic fraction of Lonicera caerulea L. fruits reduces oxidative stress and inflammatory markers induced by lipopolysaccharide in gingival fibroblasts,” Food and Chemical Toxicology, vol. 48, no. 6, pp. 1555–1561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Rosón, J. Carratalà, N. Fernández-Sabé, F. Tubau, F. Manresa, and F. Gudiol, “Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia,” Archives of Internal Medicine, vol. 164, no. 5, pp. 502–508, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. C. W. Chow, M. T. H. Abreu, T. Suzuki, and G. P. Downey, “Oxidative stress and acute lung injury,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 4, pp. 427–431, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Beck, R. Garcia, G. Heiss, P. S. Vokonas, and S. Offenbacher, “Periodontal disease and cardiovascular disease,” Journal of Periodontology, vol. 67, no. 10, pp. 1123–1137, 1996. View at Google Scholar · View at Scopus
  8. W. L. Smith, R. Michael Garavito, and D. L. DeWitt, “Prostaglandin endoperoxide H syntheses (cyclooxygenases)-1 and -2,” The Journal of Biological Chemistry, vol. 271, no. 52, pp. 33157–33160, 1996. View at Google Scholar · View at Scopus
  9. C. D. Funk, “Prostaglandins and leukotrienes: advances in eicosanoid biology,” Science, vol. 294, no. 5548, pp. 1871–1875, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Y. Wu, P. L. Chi, H. L. Hsieh, S. F. Luo, and C. M. Yang, “TLR4-dependent induction of vascular adhesion molecule-1 in rheumatoid arthritis synovial fibroblasts: roles of cytosolic phospholipase a 2α/ cyclooxygenase-2,” Journal of Cellular Physiology, vol. 223, no. 2, pp. 480–491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Morita, “Distinct functions of COX-1 and COX-2,” Prostaglandins and Other Lipid Mediators, vol. 68-69, pp. 165–175, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Mizuno, C. Sakamoto, K. Matsuda et al., “Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice,” Gastroenterology, vol. 112, no. 2, pp. 387–397, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. D. W. Gilroy, P. R. Colville-Nash, D. Willis, J. Chivers, M. J. Paul-Clark, and D. A. Willoughby, “Inducible cyclooxygenase may have anti-inflammatory properties,” Nature Medicine, vol. 5, no. 6, pp. 698–701, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Vong, J. G. P. Ferraz, R. Panaccione, P. L. Beck, and J. L. Wallace, “A pro-resolution mediator, prostaglandin D2, is specifically up-regulated in individuals in long-term remission from ulcerative colitis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 26, pp. 12023–12027, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kühn and V. B. O'Donnell, “Inflammation and immune regulation by 12/15-lipoxygenases,” Progress in Lipid Research, vol. 45, no. 4, pp. 334–356, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. B. D. Levy, “Lipoxins and lipoxin analogs in asthma,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 73, no. 3-4, pp. 231–237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. C. N. Serhan, “Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators,” Journal of Periodontology, vol. 79, no. 8, pp. 1520–1526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. O'Meara, K. Rodgers, and C. Godson, “Lipoxins: update and impact of endogenous pro-resolution lipid mediators,” Reviews of Physiology, Biochemistry and Pharmacology, vol. 160, pp. 47–70, 2008. View at Publisher · View at Google Scholar
  19. C. N. Serhan, “Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways,” Annual Review of Immunology, vol. 25, pp. 101–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. N. Serhan, S. Yacoubian, and R. Yang, “Anti-inflammatory and proresolving lipid mediators,” Annual Review of Pathology, vol. 3, pp. 279–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. B. D. Levy, “Lipoxins and lipoxin analogs in asthma,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 73, no. 3-4, pp. 231–237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Bandeira-Melo, M. F. Serra, B. L. Diaz et al., “Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia,” Journal of Immunology, vol. 164, no. 2, pp. 1029–1036, 2000. View at Google Scholar · View at Scopus
  23. C. L. Karp, L. M. Flick, K. W. Park et al., “Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway,” Nature Immunology, vol. 5, no. 4, pp. 388–392, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. C. L. Karp, L. M. Flick, R. Yang, J. Uddin, and N. A. Petasis, “Cystic fibrosis and lipoxins,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 73, no. 3-4, pp. 263–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. S. H. Wu, X. H. Wu, C. Lu, L. Dong, and Z. Q. Chen, “Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor,” American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 1, pp. 65–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Bonnans, K. Fukunaga, M. A. Levy, and B. D. Levy, “Lipoxin A4 regulates bronchial epithelial cell responses to acid injury,” American Journal of Pathology, vol. 168, no. 4, pp. 1064–1072, 2006. View at Publisher · View at Google Scholar
  27. J. C. Bonner, A. B. Rice, J. L. Ingram et al., “Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis,” American Journal of Pathology, vol. 161, no. 2, pp. 459–470, 2002. View at Google Scholar · View at Scopus
  28. R. Medeiros, G. B. Rodrigues, C. P. Figueiredo et al., “Molecular mechanisms of topical anti-inflammatory effects of lipoxin A4 in endotoxin-induced uveitis,” Molecular Pharmacology, vol. 74, no. 1, pp. 154–161, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Tamm, M. Roth, M. Malouf et al., “Primary fibroblast cell cultures from transbronchial biopsies of lung transplant recipients,” Transplantation, vol. 71, no. 2, pp. 337–339, 2001. View at Google Scholar · View at Scopus
  30. E. Motohashi, H. Kawauchi, H. Endo et al., “Regulatory expression of lipoxin A4 receptor in physiologically estrus cycle and pathologically endometriosis,” Biomedicine and Pharmacotherapy, vol. 59, no. 6, pp. 330–338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. P. Louboutin, B. A. S. Reyes, L. Agrawal, C. R. Maxwell, E. J. Van Bockstaele, and D. S. Strayer, “Blood-brain barrier abnormalities caused by exposure to HIV-1 gp120 - Protection by gene delivery of antioxidant enzymes,” Neurobiology of Disease, vol. 38, no. 2, pp. 313–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Raval, P. G. Frank, L. Laury-Kleintop, G. Yan, and S. Lanza-Jacoby, “Celecoxib combined with atorvastatin prevents progression of atherosclerosis,” Journal of Surgical Research, vol. 163, no. 2, pp. e113–e122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J. O'Brien, T. Lyons, J. Monks et al., “Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species,” American Journal of Pathology, vol. 176, no. 3, pp. 1241–1255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Lührmann, K. Grote, M. Stephan, T. Tschernig, and R. Pabst, “Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent,” Immunology Letters, vol. 108, no. 2, pp. 167–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. U. Scher and M. H. Pillinger, “15d-PGJ2: the anti-inflammatory prostaglandin?” Clinical Immunology, vol. 114, no. 2, pp. 100–109, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Estenssoro, A. Dubin, E. Laffaire et al., “Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome,” Critical Care Medicine, vol. 30, no. 11, pp. 2450–2456, 2002. View at Google Scholar · View at Scopus
  37. F. Frutos-Vivar, N. Nin, and A. Esteban, “Epidemiology of acute lung injury and acute respiratory distress syndrome,” Current Opinion in Critical Care, vol. 10, no. 1, pp. 1–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. G. D. Rubenfeld, E. Caldwell, E. Peabody et al., “Incidence and outcomes of acute lung injury,” The New England Journal of Medicine, vol. 353, no. 16, pp. 1685–1693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. L. B. Ware and M. A. Matthay, “The acute respiratory distress syndrome,” The New England Journal of Medicine, vol. 342, no. 18, pp. 1334–1349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. D. W. Gilroy, T. Lawrence, M. Perretti, and A. G. Rossi, “Inflammatory resolution: new opportunities for drug discovery,” Nature Reviews Drug Discovery, vol. 3, no. 5, pp. 401–416, 2004. View at Google Scholar · View at Scopus
  41. C. N. Serhan, “Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways,” Annual Review of Immunology, vol. 25, pp. 101–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. W. Jin, L. Zhang, Q. Q. Lian et al., “Posttreatment with aspirin-triggered lipoxin A4 analog attenuates lipopolysaccharide-induced acute lung injury in mice: the role of heme oxygenase-1,” Anesthesia and Analgesia, vol. 104, no. 2, pp. 369–377, 2007. View at Publisher · View at Google Scholar
  43. D. Takai, T. Nagase, and T. Shimizu, “New therapeutic key for cystic fibrosis: a role for lipoxins,” Nature Immunology, vol. 5, no. 4, pp. 357–358, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Tomlinson, I. Appleton, A. R. Moore et al., “Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenin-induced pleurisy,” British Journal of Pharmacology, vol. 113, no. 3, pp. 693–698, 1994. View at Google Scholar · View at Scopus
  45. K. Fukunaga, P. Kohli, C. Bonnans, L. E. Fredenburgh, and B. D. Levy, “Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury,” Journal of Immunology, vol. 174, no. 8, pp. 5033–5039, 2005. View at Google Scholar · View at Scopus
  46. C. Bandeira-Melo, M. F. Serra, B. L. Diaz et al., “Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia,” Journal of Immunology, vol. 164, no. 2, pp. 1029–1036, 2000. View at Google Scholar